Investigation the effect of Falcaria vulgaris on vitiligo
Phase 3
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT20160627028664N3
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Clinical diagnosis of vitiligo recently or in case of previous diagnosis of non-drug use from one month ago
Normal blood, liver, kidney, anti-nuclear antibody (ANA) tests and eye examination
Exclusion Criteria
Use of effective concomitant treatment in vitiligo
Pregnancy
Personal or family history of light-sensitive
Suffering from light-sensitive diseases such as lupus and porphyria
Use of light-sensitizing drugs such as retinoids and cotrimoxazole
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of skin lesions. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA.;Color of skin lesions. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA.;Follicular pigmentation. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA.
- Secondary Outcome Measures
Name Time Method